DNA catalysts
Catalysts and events linked to DNA, newest first.
DNA stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Pfizer and NVIDIA Form $80M Joint Venture in AI Biopharma Platform CytoReason 2026-09-25 · Up | commercial biosecurity and adjuvant computational contract revenue | Ginkgo Bioworks' $31M contract with SaponiQx. | Not recorded |
| Pfizer and NVIDIA Form $80M CytoReason Venture as Vaccine AI R&D Expands 2026-09-25 · Up | commercial biosecurity and adjuvant service contract revenue | Secured $31M contract with SaponiQx for AI-assisted adjuvant optimization. | Not recorded |
| Pfizer and NVIDIA Form $80M Joint Venture in AI-Driven Vaccine Discovery 2026-09-25 · Up | direct contract revenue execution with biopharma partners | Disclosed $31M contract with SaponiQx in adjuvant discovery. | Not recorded |
| Pfizer and NVIDIA Form $80M AI Venture as Vaccine Discovery Investments Top $140M 2026-09-25 · Up | biologics service contract revenue addition | Source notes Ginkgo Bioworks' $31M contract with SaponiQx. | Not recorded |
| Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine Adjuvants 2026-09-25 · Up | contract revenue expansion through synthetic biology platform licensing | Ginkgo Bioworks signed a $31M contract with SaponiQx for AI adjuvant optimization. | Not recorded |
| Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140M 2026-09-25 · Up | contract revenue addition from synthetic biology adjuvant design agreements | $31M commercial contract with SaponiQx | Not recorded |
| Pfizer and Nvidia Form $80M CytoReason AI Drug Discovery JV 2026-09-25 · Up | contract revenue additions from AI discovery agreements | Secured $31M contract with SaponiQx for adjuvant optimization. | Not recorded |
| Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant Discovery 2026-09-25 · Up | contract revenue addition | Ginkgo Bioworks secured a $31 million contract with SaponiQx. | Not recorded |
Do these developments change your position?
Review DNA alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-09-25Pfizer and Nvidia Form $80M CytoReason AI Drug Discovery JVDNA
- 2026-09-25Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140MDNA NVDA+3.95%
- 2026-09-25Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M CytoReason Venture as Vaccine AI R&D ExpandsDNA PFE
- 2026-09-25Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140MDNA NVDA+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M AI Venture as Vaccine Discovery Investments Top $140MDNA NVDA PFE+3.95%
- 2026-09-25Ginkgo Bioworks Secures $31M SaponiQx Vaccine Adjuvant ContractDNA
- 2026-09-25Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine AdjuvantsDNA
- 2026-09-25Pfizer and NVIDIA Form $80M AI Venture as Vaccine Discovery Investments Top $140MDNA NVDA PFE+3.95%
- 2026-09-25Ginkgo Bioworks Secures $31M SaponiQx Vaccine Adjuvant ContractDNA
- 2026-09-25Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140MDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M Joint Venture in AI-Driven Vaccine DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine AdjuvantsDNA
- 2026-09-25Pfizer and NVIDIA Form $80M Joint Venture in AI Biopharma Platform CytoReasonDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and Nvidia Form $80M CytoReason AI Drug Discovery JVDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M CytoReason Venture as Vaccine AI R&D ExpandsDNA NVDA PFE+3.95%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.